Scientists studying biomarkers associated with human diseases and drug responses commonly use targeted immunoassays for marker detection and quantitation. Challenges associated with conventional ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue, a leading developer of tissue biomarker identification and quantification assays for translational research and pathology labs, today announced the ...
Multiplex qPCR is a popular area of interest for many assay developers. Thanks to distinct reporter dyes, multiple reactions can be combined into a single well, with each target detected independently ...
The measurement of specific molecules in serum and plasma is essential in the diagnosis, treatment and management of many diseases. Traditional methods have used single assay techniques, whereby only ...
The tumor microenvironment is a complex mix of cancer cells, immune cells, and other components that all play a part in tumor progression, metastasis, and therapy responses. Understanding the highly ...
At virtually every stage of the processes required to bring a new drug to market—from early discovery through clinical trials—biopharma scientists would like more information. More insight into the ...
Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...
Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency for precision medicine research. HUSTON, TX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results